Glucose B. Braun

Glucose B. Braun is an intravenous solution containing glucose as the active ingredient; the specific concentration is not disclosed, and it is supplied as a sterile liquid for parenteral administration. Marketed in the European Union, this prescription‑only product is used as an energy source and volume expander in clinical settings. It belongs to the excipient/solvent class and supports fluid replacement and nutrition for patients requiring intravenous therapy.

Glucose B. Braun is indicated for several clinical situations where rapid glucose provision or fluid volume support is needed.

- Treatment of acute hypoglycemia when oral glucose is not feasible. - Component of parenteral nutrition regimens to supply carbohydrate calories. - Fluid and electrolyte replacement in patients unable to tolerate oral intake. - Volume expansion during resuscitation or peri‑operative care. - Dilution of other intravenous medications as a compatible carrier solution. - Support of metabolic needs during prolonged fasting or critical illness.

Adverse reactions to Glucose B. Braun are generally related to its osmolarity, glucose load, or infusion rate. The frequency and severity of these events depend on patient factors, infusion concentration, and monitoring practices.

Common: - Transient hyperglycemia, especially in patients with impaired glucose tolerance. - Local irritation or phlebitis at the infusion site. - Mild electrolyte shifts, such as decreased serum potassium. - Fluid overload when administered in large volumes. - Nausea or vomiting if administered rapidly.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Allergic or anaphylactic reaction to the solution components. - Hyperosmolar hyperglycemic state in susceptible individuals. - Severe electrolyte imbalance (e.g., hypernatremia) in high‑concentration solutions.

When prescribing Glucose B. Braun, clinicians should consider several precautionary measures to minimize risks and ensure appropriate use.

- Assess baseline blood glucose and adjust infusion rate in diabetic or pre‑diabetic patients. - Monitor serum electrolytes, particularly potassium and sodium, during prolonged therapy. - Evaluate fluid status to avoid overload in patients with heart or renal failure. - Use aseptic technique to prevent catheter‑related infections. - Avoid rapid infusion of high‑concentration solutions to reduce phlebitis risk. - Consider compatibility with other IV drugs before mixing in the same line.

Glucose B. Braun may interact with other medications or clinical conditions, influencing efficacy or safety.

Avoid: - Co‑administration with insulin or oral hypoglycemics without dose adjustment, which can cause severe hypoglycemia. - Simultaneous infusion of high‑dose potassium solutions, increasing risk of hyperkalemia. - Use with hyperosmolar agents (e.g., mannitol) that may exacerbate fluid shifts.

Use with caution: - Concurrent use of diuretics, requiring close monitoring of volume status and electrolytes. - Administration alongside catecholamines or glucocorticoids, which may raise blood glucose further. - Patients receiving total parenteral nutrition, where glucose load should be balanced with other macronutrients.